Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

To prove the treatment concept of the use of balloon assistance in transarterial therapy for HCC and to explore the selection criteria for clinical application of balloon assistance in transarterial therapy for HCC.

measurable disease
  • 0 views
  • 16 Aug, 2021
  • 1 location
TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

The objective of this study is to evaluate the efficacy and safety of TACE combined with Tislelizumab in patients with advanced intrahepatic cholangiocarcinoma after progression on first-line systemic therapy.

TACE
ct scan
renal function
neutrophil count
  • 0 views
  • 21 Jul, 2021
  • 1 location
A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With Hepatic Arterial Infusion Chemotherapy (HAIC) in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

The current study is to investigate the safety and efficacy of fruquintinib combined with HAIC in patients with advanced colorectal liver metastases who have failed second-line systemic standard treatment, in order to provide more survival opportunities for the second progression of advanced colorectal liver metastases.

  • 0 views
  • 22 Sep, 2022
  • 1 location
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

The purpose of this study is to evaluate the efficacy and safety of resection plus neoadjuvant hepatic arterial infusion chemotherapy (HAIC) compared with resection alone in patients with resectable hepatocellular carcinoma beyond Milan criteria.

cirrhosis
oxaliplatin
hepatic arterial infusion
platelet count
radiofrequency ablation
  • 3 views
  • 01 Mar, 2022
  • 6 locations
TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Patients With Advanced Hepatocellular Carcinoma (TASK-02)

The objective of this study is to evaluate the efficacy and safety of TACE combined with Sintilimab plus bevacizumab biosimilar in patients with advanced hepatocellular carcinoma as first-line therapy.

TACE
ct scan
renal function
neutrophil count
  • 0 views
  • 21 Jul, 2021
  • 1 location
EXALT: EXercise Attenuates Liver Tumors Trial

The overall goal of this proposal is to test the effect of exercise to delay or avert HCC recurrence and gain information regarding the potential molecular mechanisms of HCC tumor inhibition by exercise.

hepatoma
liver transplant
  • 0 views
  • 01 Mar, 2021
  • 1 location
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

The purpose of this study is to evaluate the safety and efficacy of the combination therapy with HAIC-TACE and donafenib compared to TACE plus donafenib in patients with BCLC B stage unresectable hepatocellular carcinoma (HCC) out of up-to-seven criteria.

TACE
oxaliplatin
fluorouracil
calcium
folfox
  • 0 views
  • 26 Mar, 2022
  • 1 location
Tislelizumab(Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

The aim of this study is to assess the R0 resection rate of tislelizumab combined with Lenvatinib and Gemox chemotherapy in the conversion therapy of potentially resectable locally advanced BTC.

  • 0 views
  • 19 Dec, 2021
  • 1 location
Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

It is postulated that all arterial tumor feeders supplying a HCC tumor are interconnected with each other through the tumor sinusoid, such that when one of the feeders is catheterized for delivery of a liquid embolic agent, the whole tumor sinusoid will be embolized, if the arterial blood flow in …

TACE
  • 0 views
  • 16 Aug, 2021
  • 1 location
PHP and Immunotherapy in Metastasized UM (CHOPIN)

Melanoma of the eye (ocular/uveal melanoma) is an uncommon type of cancer that is associated with a high mortality. It usually disseminates rapidly throughout the body, most commonly to the liver and lungs. In this study a combination therapy with immunotherapy (ipilimumab with nivolumab) and chemotherapy (melphalan) will be assessed …

  • 2 views
  • 23 Apr, 2022
  • 1 location